The development of low-grade cerebral edema in cirrhosis is supported by the evolution of 1H-magnetic resonance abnormalities after liver transplantation

Journal of Hepatology

Volumn 35, Issue 5, 2001, Pages 598-604

  Córdoba, Juan ^a   Alonso, Juli ^a   Rovira, Alex ^a   Jacas, Carlos ^a   Sanpedro, Francesc ^a   Castells, Lluís ^a   Vargas, Víctor ^a   Margarit, Carles ^a   Kulisewsky, Jaime ^b   Esteban, Rafael ^a   Guardia, Jaume ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

1H magnetic resonance spectroscopy; Brain edema; Cirrhosis; Hepatic encephalopathy; Liver transplant; Magnetization transfer imaging

Indexed keywords

AMMONIA; GLUTAMIC ACID; GLUTAMINE;

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN FUNCTION; BRAIN LEVEL; BRAIN METABOLISM; BRAIN WATER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOLOGICAL ASPECT;

AMMONIA; BRAIN; BRAIN EDEMA; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; REFERENCE VALUES;

EID: 0035171234     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00181-7     Document Type: Article

References (41)

1. Fulminant hepatic failure
2. Pathophysiology of cerebral edema in fulminant hepatic failure
3. Cerebral oedema and increased intracranial pressure in chronic liver disease
4. Glutamine, myo-inositol and other organic osmolytes after portacaval anastomosis in the rat. Implications for ammonia-induced brain edema
5. Magnetization transfer: Theory and clinical applications in neuroradiology
6. Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images
7. Lysolecithin-induced demyelination in primates: Preliminary in vivo study with MR and magnetization transfer
8. Localized proton magnetic resonance spectroscopy of the cerebellum in detoxifying alcoholics
9. The neurobiology of hepatic encephalopathy
10. Neuropsychological characterization and detection of subclinical hepatic encephalopathy
11. Subclinical encephalopathy
12. An empirical approach to determining criteria for abnormality in test batteries with multiple measures
13. Neurospectroscopic alterations and globus pallidus hyperintensity as related resonance markers of reversible hepatic encephalopathy
14. Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: Clinical correlations
15. Localized proton spectroscopy using stimulated echoes
16. 1H NMR chemical shift selective (CHESS) imaging
17. A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis
18. Clinical applications of magnetic resonance spectroscopy
19. Hepatic encephalopathy in chronic liver disease: A clinical manifestation of astrocyte swelling and low-grade cerebral edema?
20. Magnetization transfer contrast of various regions of the brain in liver cirrhosis
21. Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: Correlative findings of active versus irreversible plaque disease
22. Astrocytic-ammonia interactions in hepatic encephalopathy
23. Central nervous system toxicity after liver transplantation
24. Central pontine myelinolysis and cyclosporine neurotoxicity following liver transplantation
25. MR imaging of the basal ganglia in chronic liver disease: Correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status
26. Hepatic cirrhosis: Magnetization transfer contrast in the globus pallidus
27. Manganese and chronic hepatic encephalopathy
28. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction
29. 1H spectroscopy of brain metabolites in hepatic encephalopathy: Time-course of renormalization after liver transplantation
30. Improvement of magnetic resonance spectroscopic abnormalities but not pallidal hyperintensity followed amelioration of hepatic encephalopathy after occlusion of a large spleno-renal shunt
31. Basal ganglia signal intensity alterations: Reversal after discontinuation of parenteral manganese administration
32. Brain edema and hepatic encephalopathy
33. Human cerebral osmolytes during chronic hyponatremia
34. Hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis
35. Cerebral abnormalities in patients with cirrhosis detected with proton magnetic resonance spectroscopy and magnetic resonance imaging
36. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis
37. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy
38. Subclinical hepatic encephalopathy: Proton MR spectroscopic abnormalities
39. 1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve